Download PDF
Semin Reprod Med 2019; 37(05/06): 251-256
DOI: 10.1055/s-0038-1675585
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Neuroanatomy of Reproduction: Seeing Is Believing

Alexander L. Vlasak
1   College of Medicine, University of Florida, Gainesville, Florida
,
Amelia Schaub
2   Department of Obstetrics and Gynecology, University of Florida, Gainesville, Florida
,
Margaret E. Robin Barry
3   Department of Neurosurgery, University of Florida, Gainesville, Florida
,
Alice S. Rhoton-Vlasak
4   Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Florida, Gainesville, Florida
› Author Affiliations
Further Information

Publication History

Publication Date:
03 January 2019 (online)

   Permissions and Reprints

Abstract

The brain is the central controller of reproduction and the menstrual cycle. Reproductive endocrinologists spend their days treating patients with perturbations in reproduction as a result of pituitary diseases and manipulate pituitary hormones to enhance fertility and quality of life. Microscopic neuroanatomical images will allow a better understanding of how a tumor in the pituitary might affect vision, or a mass in the brain might cause amenorrhea. Clinical correlations that are taught every day become much clearer once the anatomical relationships are explored. The objective of this pictorial tour is to elucidate anatomical and clinical relationships while showcasing the neuroanatomy of reproduction.

Keywords

pituitary - reproduction - hypothalamic–pituitary axis - neuroanatomy
 

  • References

  • 1 Lunenfeld B. Historical perspectives in gonadotrophin therapy. Hum Reprod Update 2004; 10 (06) 453-467
    CrossrefPubMedGoogle Scholar
  • 2 Sellar Region | Neurosurgery | Oxford Academic. Available at: https://academic.oup.com/neurosurgery/article/51/suppl_4/S1-335/2728103 . Accessed August 30, 2018
    PubMed
  • 3 Larkin S, Ansorge O. Development and microscopic anatomy of the pituitary gland. Endotext; 2000. Available at: MDText.com, Inc.
    Google Scholar
  • 4 Asa SL, Ezzat S. The pathogenesis of pituitary tumors. Annu Rev Pathol 2009; 4: 97-126
    CrossrefPubMedGoogle Scholar
  • 5 Ostrom QT, Gittleman H, Farah P. , et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro-oncol 2013; 15 (Suppl. 02) ii1-ii56
    PubMedGoogle Scholar
  • 6 Ostrom QT, Gittleman H, Liao P. , et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro-oncol 2017; 19 (Suppl. 05) v1-v88
    CrossrefPubMedGoogle Scholar
  • 7 Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC. Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 1997; 314 (05) 287-291
    PubMedGoogle Scholar
  • 8 Chambers EF, Turski PA, LaMasters D, Newton TH. Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 1982; 144 (01) 109-113
    CrossrefPubMedGoogle Scholar
  • 9 Ezzat S, Asa SL, Couldwell WT. , et al. The prevalence of pituitary adenomas: a systematic review. Cancer 2004; 101 (03) 613-619
    CrossrefPubMedGoogle Scholar
  • 10 Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120 (10) 817-820
    CrossrefPubMedGoogle Scholar
  • 11 Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA 2017; 317 (05) 516-524
    CrossrefPubMedGoogle Scholar
  • 12 Primeau V, Raftopoulos C, Maiter D. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol 2012; 166 (05) 779-786
    CrossrefPubMedGoogle Scholar
  • 13 Inoshita N, Nishioka H. The 2017 WHO classification of pituitary adenoma: overview and comments. Brain Tumor Pathol 2018; 35 (02) 51-56
    CrossrefPubMedGoogle Scholar
  • 14 Skugor M, Hamrahian AH. Pituitary disorders. In: Carey WD, ed. Current Clinical Medicine. 2nd ed. Philadelphia, PA: Saunders/Elsevier; 2010;408-415.
    PubMed
  • 15 Ben-Shlomo A, Melmed S. Acromegaly. Endocrinol Metab Clin North Am 2008; 37 (01) 101-122 , viii
    CrossrefPubMedGoogle Scholar
  • 16 Brue T, Castinetti F. The risks of overlooking the diagnosis of secreting pituitary adenomas. Orphanet J Rare Dis 2016; 11 (01) 135
    CrossrefPubMedGoogle Scholar
  • 17 Cote DJ, Smith TR, Sandler CN. , et al. Functional gonadotroph adenomas: case series and report of literature. Neurosurgery 2016; 79 (06) 823-831
    CrossrefPubMedGoogle Scholar
  • 18 Monson JP. The epidemiology of endocrine tumours. Endocr Relat Cancer 2000; 7 (01) 29-36
    CrossrefPubMedGoogle Scholar
  • 19 Losa M, Mortini P, Barzaghi R, Franzin A, Giovanelli M. Endocrine inactive and gonadotroph adenomas: diagnosis and management. J Neurooncol 2001; 54 (02) 167-177
    CrossrefPubMedGoogle Scholar
  • 20 Kreutzer J, Buslei R, Wallaschofski H. , et al. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 2008; 158 (01) 11-18
    CrossrefPubMedGoogle Scholar